Browse diseases

…en (PSA) screening quagmire is challenging without falling into prostate cancer’s “heterogeneity black hole.” I read the 23 year follow-up of t…

…Rs were significantly elevated for all cancers combined and for stomach cancer, colorectal cancer, prostate cancer and haematopoietic malignan…

…Aims Pre-surgical risk classification tools for prostate cancer have shown better patient stratification with the addition of c…

…ng osteosarcoma (143B, SAOS2), rhabdomyosarcoma (RD, Rh30), and Ewing Sarcoma (TC71), were evaluated by ELISA for TGFB cytokine secretion. We…

…al. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nat Med. 2022;28:144–53.Koo KC, Pa…

…ers.TGF-β vaccination in the CRISPR/Cas9-driven murine model of prostate cancer led to the reduction of the total tumor burden, without affecti…

…Introduction Prostate cancer is a leading cause of cancer-related deaths among men in the US…

…ritical to avoid exacerbating existing inequities. For example, prostate cancer incidence is higher in black patients.55 Further, incidence, pa…

…nsights into the physical and psychological challenges faced by prostate cancer survivors, particularly the roles of kinesiophobia and fatigue …

…nt NM_000051.4(ATM):c.7271T>G is associated with a high risk of breast cancer (BC), but the magnitude of the association, and the association…

…rmline variant in PALB2 (c.3106G>C, p.Val1036Leu) who developed ovarian cancer. Tumour somatic analysis revealed a 24.7% loss of heterozygosit…

…adjunct in surgical pathology, particularly in the diagnosis of prostate cancer, where variability in interpretation or missed cancer foci can …